Trial Profile
Open-label, Randomized, Crossover Study to Prove Bioequivalence Between Opxion (Levonorgestrel 0.75 mg From Bayer de Mexico) and Postday (Levonorgestrel 0.75 mg From Investigacion Farmaceutica), in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jun 2012
Price :
$35
*
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Pharmacokinetics
- Acronyms LEVEQ-2
- Sponsors Bayer
- 05 Apr 2010 New trial record